oxymetazoline hydrochloride 0.5 MG/ML [Qlearquil Nasal Decongestant]
- RxCUI
- 1550034
- RxNorm name
- oxymetazoline hydrochloride 0.5 MG/ML [Qlearquil Nasal Decongestant]
- Term type
- SBDC
- Status
- Active
- Updated
- 2026-10-27 17:48:06
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102014
- Active start
- 102014
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 0.5 MG / 1 ML | oxymetazoline |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| oxymetazoline | 7812 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | oxymetazoline hydrochloride 0.5 MG/ML [Qlearquil Nasal Decongestant] | 1 | NAMES |
| RxNorm Name | oxymetazoline hydrochloride 0.5 MG/ML [Qlearquil Nasal Decongestant] | 1 | NAMES |
| TTY | SBDC | 1 | ATTRIBUTES |
| RxCUI | 1550034 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D11AX | Other dermatologicals | ATC1-4 | oxymetazoline | |
| ATC | S01GA | Sympathomimetics used as decongestants | ATC1-4 | oxymetazoline | |
| ATC | R01AB | Sympathomimetics, combinations excl. corticosteroids | ATC1-4 | oxymetazoline | |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | oxymetazoline | |
| FDASPL | D048288 | Imidazolines | CHEM | has_chemical_structure | oxymetazoline |
| FDASPL | N0000192562 | Vasoconstrictor | EPC | has_epc | oxymetazoline |
| FDASPL | N0000175651 | Increased Sympathetic Activity | PE | has_pe | oxymetazoline |
| FDASPL | N0000009908 | Vasoconstriction | PE | has_pe | oxymetazoline |
| MEDRT | D010109 | Oxymetazoline | CHEM | has_ingredient | oxymetazoline hydrochloride |
| MEDRT | D010109 | Oxymetazoline | CHEM | has_ingredient | oxymetazoline |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | oxymetazoline |
| MEDRT | D003231 | Conjunctivitis | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | D003231 | Conjunctivitis | DISEASE | may_treat | oxymetazoline |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | oxymetazoline |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | oxymetazoline |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | oxymetazoline |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | oxymetazoline hydrochloride |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | oxymetazoline |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | oxymetazoline hydrochloride |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | oxymetazoline |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | oxymetazoline hydrochloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |